Notably, mouse Apoe is somewhat similar to human APOE4 [52–55], as knocking out mouse Apoe alleles reduces Aβ plaque deposition in APP mice [55] and reduces tau-induced neurodegeneration in PS19 mice [15], mirroring the pathogenic effect of human APOE4 in AD. This evidence concerns the gene MAPT and Alzheimer disease.